Featured Research

from universities, journals, and other organizations

Overproduction Of Brain Chemical During Early Stages Of Alzheimer’s Contributes To Memory Loss In Patients

Date:
March 23, 2001
Source:
Rush Presbyterian St. Luke's Medical Center
Summary:
Overproduction of the brain chemical galanin during the early stages of Alzheimer’s may have an negative effect on the brain and contribute to the cognitive decline of patients, according to a study published in the March 20 issue of Proceeding of the National Academy of Sciences.

Overproduction of the brain chemical galanin during the early stages of Alzheimer’s may have an negative effect on the brain and contribute to the cognitive decline of patients, according to a study published in the March 20 issue of Proceeding of the National Academy of Sciences. Researchers from Rush Presbyterian-St. Luke’s Medical Center in Chicago, the University of Washington School of Medicine, and the National Institutes of Mental Health studied transgenic (mutated) mice with excessive amounts of galanin to better understand why people with Alzheimer’s disease lose their memory.

The study reports the human body may be detecting the underlying pathology of Alzheimer's and trying to rescue deteriorating brain cells with increased expression of galanin. Very early on in the disease, galanin might even be having beneficial effects. As the brain attempts to rescue itself with galanin and the disease progresses, the overexpression of galanin may become its own problem.

This excess of galanin may contribute to the cognitive decline that Alzheimer's patients and their families so dread.

The mice appear to move normally but have problems performing tasks that require them to remember where visual cues were located and had poor memory recall of scent and food odors. Scientists suggest these studies mirror memory loss in people suffering from Alzheimer’s.

Researcher Elliott J. Mufson, Ph.D, professor in the department of Neurological Sciences at Rush Presbyterian-St. Luke’s Medical Center in Chicago, is an expert in neurochemical pathology of Alzheimer’s and studies the deterioration of cholinergic (nerve fibers/nerve endings) neurons.

Mufson examined the brains of the transgenic mice and found that they have 70 percent fewer cholinergic neurons in the horizontal limb of the diagonal band of Broca, similar to what happens in humans with Alzheimer’s.

“These mice are a model of at least part of the Alzheimer’s syndrome. Now that we have this model, we can study the effects of the overexposure of galanin and how to block it. A drug that blocked galanin might be able to slow or reverse the mental damage caused by the disease.

Because Alzheimer’s is so complicated, it may be that someday people have to take a whole cocktail of drugs, such as anti-amyloids, galanin antagonists and anti-cholinesterases,” Mufson said.

Co-author Dr. Jacqueline N. Crawley, from the National Institutes of Mental Health, believes “If galanin is playing a role in the disease, then what we know as Alzheimer’s could be the result of many parallel events that themselves create complications.

The combination of cell death and inhibitory actions of galanin may be responsible for the memory losses that leaves Alzheimer’s patients unable to care for themselves." Galanin's appearance during Alzheimer's is mysterious. Alzheimer's is associated with degeneration of the brain and of cognitive function. People with Alzheimer's have fewer brain cells and reduced amounts of some important neurotransmitters. However, there is no shortage of the neurotransmitter galanin. Autopsies show that people with Alzheimer's have twice as much galanin in certain areas of the brain as peers who die of something else. In Alzheimer’s disease, excess galanin appears in the frontal cortex and surrounding the dying cholinergic neurons so characteristic of Alzheimer’s. About 4 million Americans have Alzheimer’s disease.

Rush-Presbyterian-St. Luke’s Medical Center includes the 809-bed Presbyterian-St. Luke’s Hospital; 154-bed Johnston R. Bowman Health Center for the Elderly; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and Graduate College); and seven Rush Institutes providing diagnosis, treatment and research into leading health problems. The medical center is the tertiary hub of the Rush System for Health, a comprehensive healthcare system capable of serving about two million people through its outpatient facilities and five member hospitals.


Story Source:

The above story is based on materials provided by Rush Presbyterian St. Luke's Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Rush Presbyterian St. Luke's Medical Center. "Overproduction Of Brain Chemical During Early Stages Of Alzheimer’s Contributes To Memory Loss In Patients." ScienceDaily. ScienceDaily, 23 March 2001. <www.sciencedaily.com/releases/2001/03/010321073115.htm>.
Rush Presbyterian St. Luke's Medical Center. (2001, March 23). Overproduction Of Brain Chemical During Early Stages Of Alzheimer’s Contributes To Memory Loss In Patients. ScienceDaily. Retrieved September 14, 2014 from www.sciencedaily.com/releases/2001/03/010321073115.htm
Rush Presbyterian St. Luke's Medical Center. "Overproduction Of Brain Chemical During Early Stages Of Alzheimer’s Contributes To Memory Loss In Patients." ScienceDaily. www.sciencedaily.com/releases/2001/03/010321073115.htm (accessed September 14, 2014).

Share This



More Mind & Brain News

Sunday, September 14, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
'Magic Mushrooms' Could Help Smokers Quit

'Magic Mushrooms' Could Help Smokers Quit

Newsy (Sep. 11, 2014) In a small study, researchers found that the majority of long-time smokers quit after taking psilocybin pills and undergoing therapy sessions. Video provided by Newsy
Powered by NewsLook.com
'Fat Shaming' Might Actually Cause Weight Gain

'Fat Shaming' Might Actually Cause Weight Gain

Newsy (Sep. 11, 2014) A study for University College London suggests obese people who are discriminated against gain more weight than those who are not. Video provided by Newsy
Powered by NewsLook.com
Common Sleeping, Anxiety Pills Linked To Alzheimer's

Common Sleeping, Anxiety Pills Linked To Alzheimer's

Newsy (Sep. 10, 2014) Researchers found commonly prescribed sleeping and anxiety pills such as Xanax and Valium could lead to an increased risk for Alzheimer's disease. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins